Review finds blueberry and grape polyphenols may improve vascular health
View as a Web Page
News Medical
 
  Cardiology Cardiology logo  
  The latest cardiology news from News Medical  
 A common dietary nutrient feeds a gut pathway linked to atrial fibrillationA common dietary nutrient feeds a gut pathway linked to atrial fibrillation
 
Researchers linked higher plasma TMAO to prevalent atrial fibrillation in 5,090 people and found that TMAO or choline supplementation accelerated AF onset, progression, atrial remodeling, and electrical dysfunction in mice. Inhibiting gut microbial TMA production lowered circulating TMAO and delayed AF in mice, identifying a potential therapeutic pathway that now requires human testing.
 
 
 Review finds blueberry and grape polyphenols may improve vascular healthReview finds blueberry and grape polyphenols may improve vascular health
 
A review of 37 publications found that grape- and blueberry-derived polyphenols were associated with modest improvements in cardiovascular risk markers, particularly endothelial function. However, most studies were small or short-term, frequently tested concentrated products, and measured biomarkers rather than cardiovascular events.
 
   Moderate coffee intake may support heart health, AHA saysModerate coffee intake may support heart health, AHA says
 
The American Heart Association finds that habitual coffee consumption is associated with lower risks of several cardiovascular outcomes, although most evidence comes from observational studies. Moderate intake is generally safe for most adults, while energy drinks and individual caffeine sensitivity may increase cardiovascular concerns.
 
   New study reveals massive gap in American blood pressure careNew study reveals massive gap in American blood pressure care
 
Nearly 23 million Americans with blood pressure 130/80 mm Hg or higher may be eligible for blood-pressure-lowering medications based on the 2025 American Heart Association/American College of Cardiology guideline, according to new, independent research published today in the Journal of the American Heart Association, an open access, peer-reviewed scientific journal of the American Heart Association.
 
   Small changes in one heart protein cause distinct cardiomyopathiesSmall changes in one heart protein cause distinct cardiomyopathies
 
Cardiomyopathies are a group of mostly hereditary, rare heart diseases in which the structure of the heart muscle tissue is impaired.
 
 Chinese researchers map epigenetic control of congenital heart defects
 
Chinese researchers map epigenetic control of congenital heart defectsThe findings have direct implications for clinical practice and future research. For genetic screening, the study provides a clear priority: CHD7 for outflow‑tract defects, CHD4 for chamber‑patterning anomalies, and CHD8 for ventricular dysfunction.
 
 
 Ten-million-person study links semaglutide to lower COVID-19 mortality
 
Ten-million-person study links semaglutide to lower COVID-19 mortalityResearchers analyzing claims from more than 10.1 million commercial insurance and Medicare Advantage enrollees found that semaglutide use was associated with a 49% lower adjusted hazard of COVID-19-related death. The observational findings corroborate earlier SELECT trial results but do not establish causation, making further prospective research essential.
 
 
 Scientists link genetic spelling mistakes to sudden cardiac death
 
Scientists link genetic spelling mistakes to sudden cardiac deathScientists have found that the 'sudden' cardiac death condition related to high profile deaths or major medical episodes of sports stars including Fabrice Muamba, Christian Erikson and Mark-Vivian Foe has numerous linked gene variations, or "spelling mistakes", which highlights a potentially treatable vulnerability.
 
 
 ACC introduces cardiogenic shock designation to improve heart attack care
 
ACC introduces cardiogenic shock designation to improve heart attack careThe American College of Cardiology (ACC) is introducing a new cardiogenic shock designation to improve outcomes for one of the most life-threatening complications of a heart attack.
 
 
 Bioresorbable sensor tracks deep-tissue lactate for over 10 days in animals
 
Bioresorbable sensor tracks deep-tissue lactate for over 10 days in animalsIn animal models, the flexible implant captured local metabolic warning signs before selected systemic measurements and used them to guide earlier resuscitation.
 
 
 Study reveals how DNA misfolding causes congenital heart disease
 
Study reveals how DNA misfolding causes congenital heart diseaseCongenital heart disease is the most common birth defect, affecting approximately 1 in 100 babies born each year. One of the many causes for this disorder is having only one functional copy of the gene TBX5, instead of two healthy copies, inherited from parents.
 
 
 Experts urge focus on prevention to tackle global heart failure
 
Experts urge focus on prevention to tackle global heart failureHeart failure already affects more than 60 million people worldwide and is one of the leading causes of hospitalization among people over the age of 65.
 
 
 Wearable microneedle sensor enables in vivo bioanalysis of cardiac biomarkers
 
Wearable microneedle sensor enables in vivo bioanalysis of cardiac biomarkersResearchers developed a microneedle electrochemiluminescence device that measured cardiac troponins in interstitial fluid at 30-minute intervals and detected cTnI down to 21.3 fg/mL in artificial interstitial fluid. In 15 rats and 1 pig, researchers recorded biomarker trends broadly consistent with serum ELISA results, although the wired, single-target prototype has not been tested in humans.
 
 
 AI-assisted paper test measures three cardiac biomarkers in 23 minutes
 
AI-assisted paper test measures three cardiac biomarkers in 23 minutesResearchers developed an AI-assisted dual-mode paper assay that measures cTnI, CK-MB, and NT-proBNP from 50 µL of serum in 23 minutes. In single-site analytical validation, neural networks quantified the three biomarkers across distinct concentration ranges, supporting further development for multiplexed cardiac testing at the point of care.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026